Cilostazol in Addition to Aspirin and Clopidogrel Improves Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes - Cilostazol in Addition to Aspirin and Clopidogrel Improves Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes

Description:

The goal of the trial was to evaluate treatment with aspirin, clopidogrel, and cilostazol compared with aspirin and clopidogrel in patients with acute coronary syndromes (ACS).